Table 4 Percent of patients who did not receive hormone therapy with at least 12 months follow-up achieving specified PSA nadir threshold over time.
From: Stereotactic body radiotherapy for organ-confined prostate cancer
| Percent (Number) of patients achieving specified PSA nadir | |||||
|---|---|---|---|---|---|
| 35 Gy |
6 months (40 patients) |
12 months (38 patients) |
18 months (28 patients) |
24 months (43 patients) |
30 months (32 patients) |
| < 1 ng/mL | 48% (19) | 55% (21) | 57% (16) | 88% (38) | 88% (28) |
| < .5 ng/mL | 15% (6) | 37% (14) | 46% (13) | 65% (28) | 75% (24) |
| 36.25 Gy |
6 months
(148 patients) |
12 months
(133 patients) |
18 months
(43 patients) |
24 months
(21 patients) | |
| < 1 ng/mL | 35% (53) | 45% (60) | 76% (33) | 81% (17) | |
| < .5 ng/mL | 19% (29) | 26% (34) | 51% (22) | 66% (14) | |